Meanwhile, an MMP-2 activated nanoparticle carrying EGCG dimer and immune checkpoint B7-H3 (CD276) bispecific antibodies was reported to induce the elimination of glioblastoma through increasing the ferroptosis and strengthening the immune checkpoint blockade treatment (257). The gene discussed is CD276; the disease is glioblastoma.